Healthcare ❯ Pharmaceuticals ❯ Drug Development

Weight Loss Drugs

Zepbound Mounjaro Clinical Trials Semaglutide Diabetes Medications Market Competition MariTide

Texas Sues Eli Lilly Over Alleged Physician Kickbacks for Zepbound and Mounjaro

The filing seeks to reveal whether support services steered prescribing, increasing state Medicaid costs.

Eli Lilly Raises 2025 Outlook as Tirzepatide Sales Soar, Orforglipron Misses Marks

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Pfizer Advances Daily Weight Loss Pill Amid FDA Rejection of Novo's Insulin